brought to you by the Global Hypertension Awareness, a Danish nonprofit organization (reg. # 45145409)

Renal Denervation Shows Sustained Long-Term Reductions in Blood Pressure

Share:
renal denervation reduction blood pressure

With its renal denervation procedure, Medtronic plc (MDT) reported sustained long-term reductions in blood pressure.

Compared to a controlled reference group, patients who underwent radiofrequency renal denervation with the first generation Symplicity renal denervation system showed statistically significant improvements in office and ambulatory blood pressure.

According to the company, the data contributes to a growing body of evidence supporting the durability of the Symplicity blood pressure procedure.

At the 34th Transcatheter Cardiovascular Therapeutics (TCT) conference, the annual scientific symposium of the Cardiovascular Research Foundation, the data were presented as Late-Breaking Clinical Science and published simultaneously in The Lancet.

More than 60 countries around the world have approved the Symplicity Spyral renal denervation system for commercial use. In the United States, Canada, and Japan, however, it is limited to investigational use only.

Source

Related Articles

US Surgeon General Dr. Vivek H. Murthy
News
US Surgeon General Calls to Action to Control Hypertension
cvd risk analysis
News
Risk of Heart Attack and Stroke Recalculated
machine learning for blood pressure developed
News
ML Developed at Yale To Personalize Blood Pressure Treatment
stroke occur more often among young adults
News
Significant Increase In Stroke Incidence Among Those Under 55
The Global Hypertension Awareness is a Danish nonprofit. Contact us here
Stay Informed with
Global Hypertension Awareness!

Get Exclusive Content and Breaking News!

Stay Informed with GHA Weekly Newsletter!

Get Exclusive Content and Breaking News Delivered to Your Inbox Daily!

Contact GHA

Get Exclusive Content and Breaking News Delivered to Your Inbox Daily!